Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease
- PMID: 28805587
- DOI: 10.1016/bs.irn.2017.05.034
Osteoporosis: A Hidden Nonmotor Face of Parkinson's Disease
Abstract
Osteoporosis is a "hidden nonmotor face" of Parkinson's disease and a cause of considerable morbidity in the older general population and in Parkinson's disease patients. Some regard this as a "hidden epidemic." Women are overrepresented and have considerable problems related to osteoporosis. In general osteoporosis leads to reduced mobility aggravating the motor syndrome of PD. The nonmotor aspects and impact of osteoporosis in PD have remained unexplored. Possible nonmotor consequences include a range of pain syndromes related to local pain, fractures, falls, and injuries as well as pathological fractures and radiculopathy. In addition depression, sleep dysfunction, dementia, as well as fear of falling also complicate the clinical picture. Quality of life deteriorates both for the patient and career. Pathways of care do not always include assessments for osteoporosis and needs to become obligatory particularly in older female PD patients. Active management strategies then need to be undertaken for osteoporosis in PD. Related motor and nonmotor consequences also highlight the importance of multidisciplinary treatment in PD particularly when dealing with osteoporosis.
Keywords: Bone mineral density; Nonmotor symptoms; Osteopenia; Osteoporosis; Parkinson's disease.
© 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Parkinson's disease and osteoporosis: basic and clinical implications.Expert Rev Endocrinol Metab. 2020 May;15(3):185-193. doi: 10.1080/17446651.2020.1756772. Epub 2020 Apr 26. Expert Rev Endocrinol Metab. 2020. PMID: 32336178 Free PMC article. Review.
-
Osteoporosis in Parkinson's disease.Parkinsonism Relat Disord. 2009 Jun;15(5):339-46. doi: 10.1016/j.parkreldis.2009.02.009. Epub 2009 Apr 5. Parkinsonism Relat Disord. 2009. PMID: 19346153 Review.
-
Parkinson's disease and osteoporosis.Age Ageing. 2013 Mar;42(2):156-62. doi: 10.1093/ageing/afs161. Epub 2012 Nov 6. Age Ageing. 2013. PMID: 23132148 Review.
-
Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Curr Osteoporos Rep. 2016 Oct;14(5):199-210. doi: 10.1007/s11914-016-0320-5. Curr Osteoporos Rep. 2016. PMID: 27525980 Review.
-
[Osteoporosis often occurs in Parkinson's disease patients].Ugeskr Laeger. 2014 Sep 1;176(36):V03140145. Ugeskr Laeger. 2014. PMID: 25293858 Review. Danish.
Cited by
-
The first cross-sectional comparative observational study of sexual dysfunction in Emirati and non-Emirati Parkinson's disease patients (EmPark-SD) in the United Arab Emirates.Sci Rep. 2024 Nov 21;14(1):28845. doi: 10.1038/s41598-024-79668-6. Sci Rep. 2024. PMID: 39572628 Free PMC article.
-
Bone-Derived Factors as Potential Biomarkers for Parkinson's Disease.Front Aging Neurosci. 2021 Feb 24;13:634213. doi: 10.3389/fnagi.2021.634213. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33732138 Free PMC article.
-
The relationships of vitamin D, vitamin D receptor gene polymorphisms, and vitamin D supplementation with Parkinson's disease.Transl Neurodegener. 2020 Sep 1;9(1):34. doi: 10.1186/s40035-020-00213-2. Transl Neurodegener. 2020. PMID: 32867847 Free PMC article. Review.
-
Anti-osteoporosis treatments changed body composition in postmenopausal women: A systematic review and meta-analysis.Medicine (Baltimore). 2022 Sep 9;101(36):e30522. doi: 10.1097/MD.0000000000030522. Medicine (Baltimore). 2022. PMID: 36086691 Free PMC article.
-
Current Perspectives on Aerobic Exercise in People with Parkinson's Disease.Neurotherapeutics. 2020 Oct;17(4):1418-1433. doi: 10.1007/s13311-020-00904-8. Neurotherapeutics. 2020. PMID: 32808252 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical